Pacific Biosciences Of California (PACB) FCF Margin (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly FCF Margin of 128.39% for Q1 2026, down 607.0% year-over-year from 25.32% in Q1 2025, and down 187.61% quarter-over-quarter from 44.64% in Q4 2025.
Pacific Biosciences Of California (PACB) FCF Margin (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's FCF Margin history runs 17 years deep, the most recent figure standing at 128.39% for Q1 2026.
- In Q1 2026, FCF Margin fell 607.0% year-over-year to 128.39%; the TTM figure through Mar 2026 stood at 72.62% (up 4430.0% YoY), while the FY2025 annual figure was 71.2%, up 6661.0% from the prior year.
- FCF Margin for Q1 2026 stood at 128.39%, down from 44.64% in the prior quarter.
- The five-year high for FCF Margin was 44.64% in Q4 2025, with the low at 252.99% in Q1 2023.
- The 5-year median for FCF Margin is 122.32% (2025), against an average of 142.22%.
- The sharpest annual moves came in 2022 and 2023: FCF Margin tumbled 16814 bps in 2022, then jumped 13725 bps in 2023.
- Pacific Biosciences Of California's FCF Margin stood at 239.35% in 2022, then jumped by 57 bps to 102.1% in 2023, then grew by 19 bps to 82.26% in 2024, then soared by 46 bps to 44.64% in 2025, then plunged by 188 bps to 128.39% in 2026.
- Business Quant data shows PACB's FCF Margin at 128.39% in Q1 2026, 44.64% in Q4 2025, and 48.44% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 18.73% |
| 10 | Pacific Biosciences Of California | 397.95 Mn | 161.08 Mn | 12.64 Mn | -95.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -95.21% |
| Mar 31, 2026 | -128.39% |
| Dec 31, 2025 | -44.64% |
| Sep 30, 2025 | -48.44% |
| Jun 30, 2025 | -75.26% |
| Mar 31, 2025 | -122.32% |
| Dec 31, 2024 | -82.26% |
| Sep 30, 2024 | -111.78% |
| Jun 30, 2024 | -154.78% |
| Mar 31, 2024 | -205.00% |
| Dec 31, 2023 | -102.10% |
| Sep 30, 2023 | -118.53% |
| Jun 30, 2023 | -92.51% |
| Mar 31, 2023 | -252.99% |
| Dec 31, 2022 | -239.35% |
| Sep 30, 2022 | -208.11% |
| Jun 30, 2022 | -182.09% |
| Mar 31, 2022 | -249.20% |
| Dec 31, 2021 | -95.92% |
| Jun 30, 2021 | -56.46% |